Harmony Biosciences Holdings Inc

+0.18 (+0.34%)
Earnings Announcements

Harmony Biosciences Holdings Posts Qtrly GAAP EPS $0.39

Published: 08/02/2022 11:57 GMT
Harmony Biosciences Holdings Inc (HRMY) - Harmony Biosciences Reports Second Quarter 2022 Financial Results and Business Updates.
Net Product Revenues for Quarter Ended June 30, 2022 Were $107.0 Million, Compared to $73.8 Million for Same Period in 2021.
Qtrly GAAP EPS $0.39.
Qtrly Non GAAP Adjusted $0.57 per Diluted Share.
Q2 Earnings per Share View $0.44, Revenue View $100.8 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $113.66 Million
Adjusted EPS is expected to be $0.17

Next Quarter Revenue Guidance is expected to be $124.18 Million
Next Quarter EPS Guidance is expected to be $0.53

More details on our Analysts Page.